Hippocampal hyperphosphorylated tau-induced deficiency is rescued by L-type calcium channel blockade

被引:1
|
作者
Crossley, Chelsea A. [1 ]
Omoluabi, Tamunotonye [1 ]
Torraville, Sarah E. [1 ]
Duraid, Sarah [1 ]
Maziar, Aida [1 ]
Hasan, Zia [1 ]
Rajani, Vishaal [1 ]
Ando, Kanae [2 ]
Hell, Johannes W. [3 ]
Yuan, Qi [1 ]
机构
[1] Mem Univ Newfoundland, Fac Med, Biomed Sci, 300 Prince Philip Dr, St John, NF A1B 3V6, Canada
[2] Tokyo Metropolitan Univ, Sch Sci, Dept Biol Sci, Tokyo 1920397, Japan
[3] Univ Calif Davis, Sch Med, Dept Pharmacol, Davis, CA 95616 USA
基金
加拿大健康研究院;
关键词
tau; hippocampus; Alzheimer's disease; spatial learning; L-type calcium channel; LONG-TERM POTENTIATION; CA1 PYRAMIDAL NEURONS; ALZHEIMERS-DISEASE; AMYLOID-BETA; NIMODIPINE; BRAIN; CA2+; SYNAPSES; TOXICITY; DEMENTIA;
D O I
10.1093/braincomms/fcae096
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Aging and Alzheimer's disease are associated with chronic elevations in neuronal calcium influx via L-type calcium channels. The hippocampus, a primary memory encoding structure in the brain, is more vulnerable to calcium dysregulation in Alzheimer's disease. Recent research has suggested a link between L-type calcium channels and tau hyperphosphorylation. However, the precise mechanism of L-type calcium channel-mediated tau toxicity is not understood. In this study, we seeded a human tau pseudophosphorylated at 14 amino acid sites in rat hippocampal cornu ammonis 1 region to mimic soluble pretangle tau. Impaired spatial learning was observed in human tau pseudophosphorylated at 14 amino acid sites-infused rats as early as 1-3 months and worsened at 9-10 months post-infusion. Rats infused with wild-type human tau exhibited milder behavioural deficiency only at 9-10 months post-infusion. No tangles or plaques were observed in all time points examined in both human tau pseudophosphorylated at 14 amino acid sites and human tau-infused brains. However, human tau pseudophosphorylated at 14 amino acid sites-infused hippocampus exhibited a higher amount of tau phosphorylation at S262 and S356 than the human tau-infused rats at 3 months post-infusion, paralleling the behavioural deficiency observed in human tau pseudophosphorylated at 14 amino acid sites-infused rats. Neuroinflammation indexed by increased Iba1 in the cornu ammonis 1 was observed in human tau pseudophosphorylated at 14 amino acid sites-infused rats at 1-3 but not 9 months post-infusion. Spatial learning deficiency in human tau pseudophosphorylated at 14 amino acid sites-infused rats at 1-3 months post-infusion was paralleled by decreased neuronal excitability, impaired NMDA receptor-dependent long-term potentiation and augmented L-type calcium channel-dependent long-term potentiation at the cornu ammonis 1 synapses. L-type calcium channel expression was elevated in the soma of the cornu ammonis 1 neurons in human tau pseudophosphorylated at 14 amino acid sites-infused rats. Chronic L-type calcium channel blockade with nimodipine injections for 6 weeks normalized neuronal excitability and synaptic plasticity and rescued spatial learning deficiency in human tau pseudophosphorylated at 14 amino acid sites-infused rats. The early onset of L-type calcium channel-mediated pretangle tau pathology and rectification by nimodipine in our model have significant implications for preclinical Alzheimer's disease prevention and intervention. Crossley et al. demonstrate experimentally, for the first time, that normalizing a calcium channel that is upregulated in a selective memory encoding brain structure in Alzheimer's disease, could prevent spatial memory deficiency associated with pretangle tau, an abnormal protein implicated in preclinical Alzheimer's disease. Graphical Abstract
引用
收藏
页数:14
相关论文
共 50 条
  • [41] N- and L-type calcium channel involvement in depolarization induced suppression of inhibition in rat hippocampal CA1 cells
    Lenz, RA
    Wagner, JJ
    Alger, BE
    JOURNAL OF PHYSIOLOGY-LONDON, 1998, 512 (01): : 61 - 73
  • [42] Inhibition of type A GABA receptors by L-type calcium channel blockers
    Das, P
    Bell-Horner, CL
    Huang, RQ
    Raut, A
    Gonzales, EB
    Chen, ZL
    Covey, DF
    Dillon, GH
    NEUROSCIENCE, 2004, 124 (01) : 195 - 206
  • [43] Mouse models to study L-type calcium channel function
    Moosmang, S
    Lenhardt, P
    Haider, N
    Hofmann, F
    Wegener, JW
    PHARMACOLOGY & THERAPEUTICS, 2005, 106 (03) : 347 - 355
  • [44] Aldosterone blocking effect of l-type calcium channel blockers
    Kawano, Hiroaki
    Yano, Katsusuke
    CIRCULATION, 2006, 114 (18) : 773 - 773
  • [45] The in vitro assessment of L-type calcium channel safety liability
    Armstrong, Duncan
    Morton, Michael
    JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2014, 70 (03) : 315 - 315
  • [46] L-type voltage-gated calcium channel blockade with isradipine as a therapeutic strategy for Alzheimer's disease
    Anekonda, Thimmappa S.
    Quinn, Joseph F.
    Harris, Christopher
    Frahler, Kate
    Wadsworth, Teri L.
    Woltjer, Randall L.
    NEUROBIOLOGY OF DISEASE, 2011, 41 (01) : 62 - 70
  • [47] NADPH redox regulates L-type calcium channel activity
    Watanabe, M
    Fan, L
    Tsujikawa, H
    Ochi, R
    Okada, T
    Gupte, SA
    FASEB JOURNAL, 2006, 20 (04): : A328 - A329
  • [48] Mechanisms of dihydropyridine - L-type calcium channel interaction.
    Wappl, E
    Mitterdorfer, J
    Glossmann, H
    Striessnig, J
    BIOPHYSICAL JOURNAL, 2001, 80 (01) : 450A - 450A
  • [49] Stac gets the skeletal L-type calcium channel unstuck
    Weiss, Norbert
    GENERAL PHYSIOLOGY AND BIOPHYSICS, 2015, 34 (02) : 101 - 103
  • [50] Biophysical comparison of two L-type calcium channel agonists
    Gonzalez, PK
    Rittenhouse, AR
    JOURNAL OF GENERAL PHYSIOLOGY, 1998, 112 (01): : 19A - 19A